|
Re: Not good news..
lizbeth thank you but no I am absolutly not qualifying for any
I thought I was PI3K mutated but I am not I am P53 mutated only and her2 I am PI3k negative PTEN negative and BRAF negative FGR negative and EGFR negative
I am therefore not qualifying for any and now that I have had herc lapatinib TDM1 and this last one it is 4 her2 targetted treatments it is over most her2 new product trials phase 1 which usually is max of 3 prior anti her2..
I feel like swearing a lot in between the tears
__________________
35 y/o
June 06: BC stage I
Grade 3; ER/PR neg
Her-2+++; lumpectomies
Aug 06: Stage IV
liver mets: 6 tumours
July 06 to Jan 07: 2*FEC+6*Taxotere; 3*TACE; LITT
March 07- Sept 07: Vaccination trial (phase 2, peptide based) at the UW (Seattle).
Herceptin since 2006
NED til Oct 09
Recurrence Oct 2009: to internal mammary gland since October 2009 missed on Oct and March 2010 scan.. palpable nodes in May 2010 when I realised..
Nov 2011:7 mets to lungs progressing fast failed hercp/tykerb/xeloda combo..
superior vena cava blocked: stent but face remains puffy
April 2012: Teresa Trial, randomised to TDM1
Nov 2012 progressing on TDM1
Dec 2012 blockage of my airways by tumours, obliteration of these blocking tumours breathing better but hoping for more- at mo too many tumours to count in the lungs and nodes.
Dec 2012 Starting new trial S-222611 phase 1b dual egfr her2+ inhibitor.
'Under no circumstances should you lose hope..' Dalai Lama
Last edited by fullofbeans; 03-24-2013 at 06:28 PM..
|
Hybrid Mode
